Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deng-Chyang Wu

Showing results (11-20 of 389) with videos related to

Pageof 39
Sort By:
The American Journal of Gastroenterology|December 18, 2025
Reply to Zhao et alPing-I Hsu, Deng-Chyang Wu, Chih-An Shih, et al.
Microorganisms|April 26, 2025
Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for <i>Helicobacter pylori</i> Infection: A Systematic ReviewChih-An Shih, Deng-Chyang Wu, Chang-Bih Shie, et al.
Helicobacter|March 26, 2011
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 daysPing-I Hsu, Deng-Chyang Wu, Jeng-Yih Wu, et al.
Helicobacter|March 26, 2011
Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?Ping I Hsu, Deng-Chyang Wu, Jeng-Yih Wu, et al.
World Journal of Gastroenterology|November 3, 2011
A new look at anti-Helicobacter pylori therapySeng-Kee Chuah, Feng-Woei Tsay, Ping-I Hsu, et al.
The Kaohsiung Journal of Medical Sciences|March 6, 2016
Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell linesZu-Yau Lin, Chao-Hung Kuo, Deng-Chyang Wu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 3, 2022
Multiple oxidative and advanced oxidative modifications of hemoglobin in gastric cancer patients measured by nanoflow LC-MS/MSDeng-Chyang Wu, Tzu-Chun Yang, Shun-Xiang Hu, et al.
Chemical Research in Toxicology|November 11, 2022
Characterization and Quantification of Acrolein-Induced Modifications in Hemoglobin by Mass Spectrometry─Effect of Cigarette SmokingHauh-Jyun Candy Chen, Shu-Wei Cheng, Nai-Ying Chen, et al.
Cells|October 15, 2024
Vulnerability of Antioxidant Drug Therapies on Targeting the Nrf2-Trp53-Jdp2 Axis in Controlling TumorigenesisYing-Chu Lin, Chia-Chen Ku, Kenly Wuputra, et al.
Stem Cell Research & Therapy|February 23, 2025
Transplantation of gastric epithelial mitochondria into human gastric cancer cells inhibits tumor growth and enhances chemosensitivity by reducing cancer stemness and modulating gastric cancer metabolismHsin-Yi Tsai, Kuen-Jang Tsai, Deng-Chyang Wu, et al.
Pageof 39

Showing results (11-20 of 389) with videos related to

Sort By:
Pageof 39
The American Journal of Gastroenterology|December 18, 2025
Reply to Zhao et alPing-I Hsu, Deng-Chyang Wu, Chih-An Shih, et al.
Microorganisms|April 26, 2025
Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for <i>Helicobacter pylori</i> Infection: A Systematic ReviewChih-An Shih, Deng-Chyang Wu, Chang-Bih Shie, et al.
Helicobacter|March 26, 2011
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 daysPing-I Hsu, Deng-Chyang Wu, Jeng-Yih Wu, et al.
Helicobacter|March 26, 2011
Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?Ping I Hsu, Deng-Chyang Wu, Jeng-Yih Wu, et al.
World Journal of Gastroenterology|November 3, 2011
A new look at anti-Helicobacter pylori therapySeng-Kee Chuah, Feng-Woei Tsay, Ping-I Hsu, et al.
The Kaohsiung Journal of Medical Sciences|March 6, 2016
Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell linesZu-Yau Lin, Chao-Hung Kuo, Deng-Chyang Wu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 3, 2022
Multiple oxidative and advanced oxidative modifications of hemoglobin in gastric cancer patients measured by nanoflow LC-MS/MSDeng-Chyang Wu, Tzu-Chun Yang, Shun-Xiang Hu, et al.
Chemical Research in Toxicology|November 11, 2022
Characterization and Quantification of Acrolein-Induced Modifications in Hemoglobin by Mass Spectrometry─Effect of Cigarette SmokingHauh-Jyun Candy Chen, Shu-Wei Cheng, Nai-Ying Chen, et al.
Cells|October 15, 2024
Vulnerability of Antioxidant Drug Therapies on Targeting the Nrf2-Trp53-Jdp2 Axis in Controlling TumorigenesisYing-Chu Lin, Chia-Chen Ku, Kenly Wuputra, et al.
Stem Cell Research & Therapy|February 23, 2025
Transplantation of gastric epithelial mitochondria into human gastric cancer cells inhibits tumor growth and enhances chemosensitivity by reducing cancer stemness and modulating gastric cancer metabolismHsin-Yi Tsai, Kuen-Jang Tsai, Deng-Chyang Wu, et al.
Pageof 39